Market research
002550.SHE Changzhou Qianhong Biopharma CO.,LTD
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 8B
- P/E ratio
- 28.78
- Analyst target
- 7
- Dividend yield
- 2.3%
- Beta
- 0.02
Community
Investor discussion
1 comment
Sign in to join the 002550.SHE discussion.
5 years, 5 months ago
Changzhou Qianhong Biopharma CO.,LTD is currently in a long term downtrend where the price is trading 2.0% below its 200 day moving average.
From a valuation standpoint, the stock is 70.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Changzhou Qianhong Biopharma CO.,LTD's total revenue rose by 68.7% to $508M since the same quarter in the previous year.
Its net income has increased by 78.4% to $83M since the same quarter in the previous year.
Finally, its free cash flow grew by 147.8% to $162M since the same quarter in the previous year.
Based on the above factors, Changzhou Qianhong Biopharma CO.,LTD gets an overall score of 4/5.